Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.05 USD | +1.24% | -0.76% | -8.67% |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.67% | 235M | |
+30.93% | 456B | |
+32.17% | 280B | |
+5.85% | 134B | |
+29.18% | 94.31B | |
+5.31% | 91.48B | |
+59.28% | 60.48B | |
+14.05% | 46.13B | |
+25.91% | 37.31B | |
-0.06% | 35.48B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Piper Sandler Initiates Coverage on OptimizeRx With Neutral Rating, $29 Price Target